Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-03

FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CAPTOPRIL (captopril) from Hikma Pharmaceuticals USA Inc. under an ANDA. The action concerns a generic captopril…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CAPTOPRIL (Captopril)

Snippet

SUPPL AP for CAPTOPRIL (CAPTOPRIL)